Profile
Full Name
Neuronetics, Inc.Ticker Symbol
STIMExchange
NASDAQSector
HealthcareIndustry
Diagnostics & ResearchCountry
United StatesIPO
June 28, 2018Indexes
Not includedWebsite
http://neurostar.comEmployees
716Key Details
Price
$4.08(+22.89%)
Market cap
$268.52M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$74.89M(+4.96% YoY)
Annual EPS
-$1.38(-31.43% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Neuronetics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 5, 25 Citizens Capital Markets
Market OutperformMar 5, 25 Canaccord Genuity
BuyAug 14, 24 JMP Securities
Market OutperformAug 13, 24 Canaccord Genuity
BuyAug 12, 24 William Blair
Market PerformMay 14, 24 William Blair
OutperformMar 6, 24 Piper Sandler
OverweightMay 10, 23 JMP Securities
Market OutperformMar 8, 23 JMP Securities
Market OutperformMar 8, 23 Canaccord Genuity
BuyInstitutional Ownership
- What is the ticker symbol for Neuronetics?
- Does Neuronetics pay dividends?
- What sector is Neuronetics in?
- What industry is Neuronetics in?
- What country is Neuronetics based in?
- When did Neuronetics go public?
- Is Neuronetics in the S&P 500?
- Is Neuronetics in the NASDAQ 100?
- Is Neuronetics in the Dow Jones?
- When was Neuronetics's last earnings report?
- When does Neuronetics report earnings?
- Should I buy Neuronetics stock now?
What is the ticker symbol for Neuronetics?
The ticker symbol for Neuronetics is NASDAQ:STIM
Does Neuronetics pay dividends?
No, Neuronetics does not pay dividends
What sector is Neuronetics in?
Neuronetics is in the Healthcare sector
What industry is Neuronetics in?
Neuronetics is in the Diagnostics & Research industry
What country is Neuronetics based in?
Neuronetics is headquartered in United States
When did Neuronetics go public?
Neuronetics's initial public offering (IPO) was on June 28, 2018
Is Neuronetics in the S&P 500?
No, Neuronetics is not included in the S&P 500 index
Is Neuronetics in the NASDAQ 100?
No, Neuronetics is not included in the NASDAQ 100 index
Is Neuronetics in the Dow Jones?
No, Neuronetics is not included in the Dow Jones index
When was Neuronetics's last earnings report?
Neuronetics's most recent earnings report was on Mar 4, 2025
When does Neuronetics report earnings?
The next expected earnings date for Neuronetics is May 7, 2025
Should I buy Neuronetics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions